C07D

Technology

Watch 206Status Updates

Stats

Description

HETEROCYCLIC COMPOUNDS

Subclasses

SubclassTitle
201/00 Preparation, separation, purification, or stabilisation of unsubstituted lactams
201/02 Preparation, separation, purification, or stabilisation of unsubstituted lactams Preparation of lactams
201/04 Preparation, separation, purification, or stabilisation of unsubstituted lactams Preparation of lactams from or via oximes by Beckmann rearrangement
201/06 Preparation, separation, purification, or stabilisation of unsubstituted lactams Preparation of lactams from or via oximes by Beckmann rearrangement from ketones by simultaneous oxime formation and rearrangement
201/08 Preparation, separation, purification, or stabilisation of unsubstituted lactams Preparation of lactams from carboxylic acids or derivatives thereof, e.g. hydroxy carboxylic acids, lactones, nitriles
201/10 Preparation, separation, purification, or stabilisation of unsubstituted lactams Preparation of lactams from cycloaliphatic compounds by simultaneous nitrosylation and rearrangement
201/12 Preparation, separation, purification, or stabilisation of unsubstituted lactams Preparation of lactams by depolymerising polyamides
201/14 Preparation, separation, purification, or stabilisation of unsubstituted lactams Preparation of salts or adducts of lactams
201/16 Preparation, separation, purification, or stabilisation of unsubstituted lactams Separation or purification
201/18 Preparation, separation, purification, or stabilisation of unsubstituted lactams Stabilisation
203/00 Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
203/02 Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom Preparation by ring-closure
203/04 Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
203/06 Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
203/08 Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom
203/10 Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom Radicals substituted by singly bound oxygen atoms
203/12 Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom Radicals substituted by nitrogen atoms not forming part of a nitro radical
203/14 Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom with carbocyclic rings directly attached to the ring nitrogen atom
203/16 Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with acylated ring nitrogen atoms
203/18 Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with acylated ring nitrogen atoms by carboxylic acids, or by sulfur or nitrogen analogues thereof

more results

Recent Patents

Not Available

Recent Publications

Publication #TitleFiling DatePub DatePatent Owner
2025/0114,305 LIPIDIC COMPOUNDS, AND USES THEREOFJan 16, 23Apr 10, 25Not available
2025/0114,326 POLAR MARINE-DERIVED MACROCYCLIC LACTAM COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOFNov 25, 22Apr 10, 25RENJI HOSPITAL, SCHOOL OF MEDICINE, SHANGHAI JIAO TONG UNIVERSITY
2025/0114,327 COMPOSITION COMPRISING TETRACYCLIC COMPOUNDMay 07, 24Apr 10, 25Chugai Seiyaku Kabushiki Kaisha
2025/0114,338 TETRAHYDRO-PYRIDO[3,4-b]INDOLE ESTROGEN RECEPTOR MODULATORS AND USES THEREOFDec 18, 24Apr 10, 25Genentech, Inc.
2025/0114,345 COMPOUNDS AND COMPOSITIONS AS CBP/P300 DEGRADERS AND USES THEREOFAug 30, 24Apr 10, 25Not available
2025/0114,356 INDAZOLE BASED COMPOUNDS AND ASSOCIATED METHODS OF USEAug 05, 24Apr 10, 25Not available
2025/0114,357 BIFUNCTIONAL PROTAC AND MOLECULAR GLUE COMPOUNDS AND METHODS OF USE THEREOFOct 09, 24Apr 10, 25Not available
2025/0114,361 PYRAZOLOPYRIMIDINE COMPOUND AND PHARMACEUTICAL USE THEREOFAug 28, 23Apr 10, 25Not available
2025/0114,369 COMPOUNDS AND METHODS FOR TREATMENT OF VIRAL INFECTIONSSep 13, 24Apr 10, 25Not available
2025/0114,374 BCL-2 INHIBITORSDec 19, 22Apr 10, 25Not available
2025/0114,380 SMALL MOLECULE CD38 INHIBITORS AND METHODS OF USING SAMEJun 10, 24Apr 10, 25President and Fellows of Harvard College; Mayo Foundation for Medical Education and Research;
2025/0114,428 DIPEPTIDOMIMETICS AS INHIBITORS OF HUMAN IMMUNOPROTEASOMESMay 03, 24Apr 10, 25Not available
2025/0114,647 ANTIBODY-DRUG CONJUGATES COMPRISING SUBSTITUTED BENZO[e]PYRROLO[1,2-a][1,4]DIAZEPINESDec 12, 24Apr 10, 25Daiichi Sankyo Company Limited
2025/0115,545 TERPENE-CONTAINING LIPIDOIDS FOR GENE DELIVERYJan 20, 23Apr 10, 25Not available
2025/0115,546 LINKERS FOR ANTIBODY DRUG CONJUGATESAug 20, 24Apr 10, 25Not available
2025/0115,548 COMPOUNDS AS SOLUBLE EPOXIDE HYDROLASE INHIBITORSOct 14, 24Apr 10, 25Not available
2025/0115,551 SYNTHESIS OF RAS INHIBITORSOct 02, 24Apr 10, 25Not available
2025/0115,552 CRYSTALLINE HYDROCHLORIDE SALTS OF N-ETHYL-2-(5-FLUORO-1H-INDOL-3-YL)-N-METHYLETHAN-1-AMINEOct 29, 24Apr 10, 25Gilgamesh Pharmaceuticals, Inc.
2025/0115,553 AN EFFICIENT NEW PROCESS FOR SYNTHESIS OF 2-AMINO-5-CHLORO-N-,3-DIMETHYLBENZAMIDEOct 10, 23Apr 10, 25Not available
2025/0115,554 NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT AND ELECTRONIC DEVICEMay 15, 23Apr 10, 25Not available

more results

Top Owners in This Class

Upgrade to the Professional Level to view Top Owners for this Class.Learn More

Applications Filed in This Class - By Year

Patents Issued To Date - By Filing Year

Average Time to Issuance